Skip to content

Enhanced recovery on the prevention of perioperative venous thromboembolism for gynecologic cancer surgical patients: a randomized controlled clinical study

Enhanced recovery on the prevention of perioperative venous thromboembolism for gynecologic cancer surgical patients: a randomized controlled clinical study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045769
Enrollment
Unknown
Registered
2021-04-24
Start date
2021-05-06
Completion date
Unknown
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic cancer

Interventions

ERAS group:Enhanced recovery care in the perioperative period
Traditional group:Traditional perioperative care

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Surgical patients with cervical cancer, ovarian cancer, uterine malignancy, and meet the indications of operation; 2.Aged 18 to 75 years, non-pregnant state; 3.Agree to participate in this experiment.

Exclusion criteria

Exclusion criteria: 1.Complicating with anaesthetic and surgical contraindications; 2.Suffered other malignant tumors in the past; 3.There was a history of severe s pelvic and peritoneal adhesion, and a history of intestinal obstruction; 4.ALT >= 3 x ULNCcr = 1.5 x ULN; 5.The history of mental illness; 6.Preoperative Carprini single score >=3; 7.Take opioids in the last 30 days; 8.Preoperative use of anticoagulant drugs, such as warfarin, sufarin, because of physical disease; 9.Preoperative use of antiplatelet agglutination drugs, such as aspirin and clopidogrel, for therapeutic purposes; 10.Severe malnutrition; 11.Severe anxiety or depression; 12.Self-care ability score < 100.

Design outcomes

Primary

MeasureTime frame
incidence of venous thromboembolism;

Secondary

MeasureTime frame
hypercoagulability of the blood;length of stay;surgical complications up to 28 days after surgery;rate of unplaned readmission up to 28 days after surgery;patient satisfaction;

Countries

China

Contacts

Public ContactGuo Xiaoqing

Shanghai First Maternity and Infant Hospital

xiaoqing_guo@tongji.edu.cn+86 18117203488

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026